Анналы клинических и лабораторных исследований

  • ISSN: 2386-5180
  • Индекс Хирша журнала: 17
  • Оценка цитируемости журнала: 6.26
  • Импакт-фактор журнала: 5.31
Индексировано в
  • Журнал GenamicsSeek
  • Китайская национальная инфраструктура знаний (CNKI)
  • CiteFactor
  • Справочник индексации исследовательских журналов (DRJI)
  • Паблоны
  • Евро Паб
  • Google Scholar
  • Секретные лаборатории поисковых систем
Поделиться этой страницей


Examining the Executives' Proposals to Competitors for Type 1 Diabetes

Bradley Alkabbani*

Competitors with type 1 diabetes (T1D) experience new challenges maintaining optimal glucose levels and as a result need specialised guidance from their medical services providers. In this, we hope to compile and analyse recommendations targeted at T1D the executives in rivals' efficient position articulations and commonly used clinical practise guidelines. The objective is to assess the available proposals under the presumption that they are comprehensive enough for competitors to apply to superior execution sport. Extension of clinical practise guidelines may be possible in order to increase the breadth and depth of proposals for superior execution competitors.